American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$218M |
| 2 |
SLB Ltd
SLB
|
+$218M |
| 3 |
Martin Marietta Materials
MLM
|
+$202M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$196M |
| 5 |
Altria Group
MO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$340M |
| 2 |
Sysco
SYY
|
+$223M |
| 3 |
CERN
Cerner Corp
CERN
|
+$185M |
| 4 |
SBA Communications
SBAC
|
+$163M |
| 5 |
Philip Morris
PM
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13% |
| 2 | Financials | 12.64% |
| 3 | Technology | 11.88% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Industrials | 10.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LMNX
951
DELISTED
Luminex Corp
LMNX
| $2.53M | ﹤0.01% |
130,245
-29,830
| -19% | -$568K |
|
952
J&J Snack Foods
JJSF
$1.67B
| $2.52M | ﹤0.01% |
23,319
+730
| +3% | +$78.8K |
|
|
TWOU
953
DELISTED
2U Inc
TWOU
| $2.52M | ﹤0.01% |
3,715
-597
| -14% | -$378K |
|
954
Amdocs
DOX
$6.08B
| $2.52M | ﹤0.01% |
41,634
-513,462
| -92% | -$28.8M |
|
955
iShares S&P GSCI Commodity-Indexed Trust
GSG
$944M
| $2.5M | ﹤0.01% |
181,241
-19,884
| -10% | -$265K |
|
|
DEST
956
DELISTED
Destination Maternity Corporation
DEST
| $2.48M | ﹤0.01% |
362,779
-170,085
| -32% | -$1.28M |
|
|
SHLX
957
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $2.46M | ﹤0.01% |
+67,225
| New | +$2.37M |
|
958
Lazard
LAZ
$4.24B
| $2.45M | ﹤0.01% |
63,163
+1,976
| +3% | +$70.9K |
|
959
Bruker
BRKR
$9.03B
| $2.44M | ﹤0.01% |
87,092
-2,474
| -3% | -$61.7K |
|
960
Pan American Silver
PAAS
$22.1B
| $2.43M | ﹤0.01% |
223,570
-18,600
| -8% | -$159K |
|
961
Anika Therapeutics
ANIK
$295M
| $2.41M | ﹤0.01% |
53,813
+2,296
| +4% | +$93.1K |
|
962
Ultragenyx Pharmaceutical
RARE
$2.65B
| $2.39M | ﹤0.01% |
37,692
-1,464
| -4% | -$95.8K |
|
963
Acadia Pharmaceuticals
ACAD
$5.07B
| $2.37M | ﹤0.01% |
84,903
-453
| -0.5% | -$9.88K |
|
964
Rambus
RMBS
$11B
| $2.37M | ﹤0.01% |
172,596
+7,757
| +5% | +$96.2K |
|
965
Patrick Industries
PATK
$2.79B
| $2.36M | ﹤0.01% |
116,827
-1,125
| -1% | -$19.6K |
|
|
ARGO
966
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $2.35M | ﹤0.01% |
51,760
+2,119
| +4% | +$93.8K |
|
|
ACOR
967
DELISTED
Acorda Therapeutics
ACOR
| $2.34M | ﹤0.01% |
738
-669
| -48% | -$2.78M |
|
968
Principal Financial Group
PFG
$24.4B
| $2.34M | ﹤0.01% |
59,301
-243,179
| -80% | -$9.36M |
|
|
HMSY
969
DELISTED
HMS Holdings Corp.
HMSY
| $2.34M | ﹤0.01% |
163,020
-162,941
| -50% | -$2.02M |
|
970
Repligen
RGEN
$9.35B
| $2.32M | ﹤0.01% |
86,419
+44,155
| +104% | +$1.08M |
|
|
NPTN
971
DELISTED
NEOPHOTONICS CORP
NPTN
| $2.31M | ﹤0.01% |
164,629
+9,494
| +6% | +$98.2K |
|
972
Supernus Pharmaceuticals
SUPN
$2.78B
| $2.29M | ﹤0.01% |
+150,172
| New | +$1.96M |
|
|
FNHC
973
DELISTED
FedNat Holding Company Common Stock
FNHC
| $2.29M | ﹤0.01% |
116,218
+3,919
| +3% | +$91.2K |
|
974
iShares MSCI EAFE Value ETF
EFV
$30.1B
| $2.27M | ﹤0.01% |
50,666
+23,600
| +87% | +$1.02M |
|
|
KAMN
975
DELISTED
Kaman Corp
KAMN
| $2.25M | ﹤0.01% |
52,649
-137,924
| -72% | -$5.62M |
|
Similar funds
American Century Companies's Q1 2016 Portfolio in Review
As of Q1 2016, American Century Companies held 1,453 positions worth $85.7B, up 0.43% from $85.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
American Century Companies's Q1 2016 filing shows 162 new, 593 increased, 512 reduced and 164 closed positions. Its largest new stake was Martin Marietta Materials: 1,466,199 shares worth $234M. The largest sale was Amazon, an estimated $340M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.
- American Century Companies's largest Q1 2016 buy was Martin Marietta Materials: 1,466,199 shares worth $234M.
- American Century Companies added most to Procter & Gamble in Q1 2016, an estimated $218M increase.
- American Century Companies's biggest Q1 2016 reduction was Amazon, cutting an estimated $340M.
- American Century Companies fully exited Kansas City Southern in Q1 2016, selling an estimated $93M.
- American Century Companies's ten largest holdings make up 13% of its $85.7B portfolio in Q1 2016.
- American Century Companies opened 162 new positions and closed 164 in Q1 2016.
- American Century Companies's portfolio value rose 0.43% quarter-over-quarter to $85.7B.
Based on American Century Companies's 13F filing for Q1 2016, filed 2 May 2016.